
Akt1Akt2-IN-17
CAS No. 893422-47-4
Akt1Akt2-IN-17 ( Akt Inhibitor 17 | Akti_2008 | Akti 2008 | Akti2008 | Akti-2008 | Akt Inhibitor 17 )
产品货号. M16440 CAS No. 893422-47-4
一种有效的选择性 Akt1 和 Akt2 双重抑制剂,IC50 分别为 3.5 nM 和 42 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2811 | 有现货 |
![]() ![]() |
50MG | ¥12069 | 有现货 |
![]() ![]() |
100MG | ¥16119 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Akt1Akt2-IN-17
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述一种有效的选择性 Akt1 和 Akt2 双重抑制剂,IC50 分别为 3.5 nM 和 42 nM。
-
产品描述A potent, selective dual Akt1 and Akt2 inhibitor with IC50 of 3.5 nM and 42 nM, respectively; shows selectivity for Akt1/2 over Akt3 (IC50=1900 nM), and highly selective over other members of the AGC family of kinases; inhibit the growth of A2780 tumors in vivo; shows good physical properties and PK profile.Lung Cancer Preclinical.
-
体外实验Consistent with the allosteric mode of inhibition, Akt1/Akt2-IN-1 (Compound 17) is dependent on the PH-domain for Akt inhibition, is selective for Akt1/2 over Akt3 (IC50=1900 nM), and is highly selective over other members of the AGC family of kinases (>50 μM vs PKA, PKC, SGK). Akt1/Akt2-IN-1 has moderate activity in an hERG binding assay (IC50=5610 nM) and is a substrate for human P-glycoprotein.
-
体内实验Akt1/Akt2-IN-1 (Compound 17) is well tolerated in at exposures that provide high levels of Akt1 and 2 inhibition in vivo. Akt1/Akt2-IN-1 has also been shown to inhibit the growth of A2780 tumors in vivo when used as monotherapy. Akt1/Akt2-IN-1 has potent inhibitory activity against Akt1 and 2 in vivo in a mouse lung and efficacy in a tumor xenograft model. Akt1/Akt2-IN-1 shows good pharmacokinetics in rat with a low clearance of 4.6 mL/min/kg and a half-life of 3.8 h. Due to the improved cell potency, physical properties, and rodent pharmacokinetics of Akt1/Akt2-IN-1, tolerability and Akt inhibition are assessed in mice. Using an acute dosing schedule (IP dosing of 50 mg/kg at times 0, 3, and 8 h), administration of Akt1/Akt2-IN-1 is well tolerated in mice and shows high levels of Akt inhibition in mouse lung.
-
同义词Akt Inhibitor 17 | Akti_2008 | Akti 2008 | Akti2008 | Akti-2008 | Akt Inhibitor 17
-
通路PI3K/Akt/mTOR signaling
-
靶点Akt
-
受体Akt
-
研究领域Cancer
-
适应症Lung Cancer
化学信息
-
CAS Number893422-47-4
-
分子量539.6296
-
分子式C33H29N7O
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 35 mg/mL
-
SMILESO=C1C2=C(N=C(C3=CC=C(CN4CCC(C5=NNC(C6=NC=CC=C6)=N5)CC4)C=C3)C(C7=CC=CC=C7)=C2)C=CN1
-
化学全称1,6-Naphthyridin-5(6H)-one, 3-phenyl-2-[4-[[4-[5-(2-pyridinyl)-1H-1,2,4-triazol-3-yl]-1-piperidinyl]methyl]phenyl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Bilodeau MT, et al. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3178-82.
2. Li Y, et al. Bioorg Med Chem Lett. 2009 Feb 1;19(3):834-6.
产品手册




关联产品
-
BAY-1125976
一种有效且高度选择性的变构 AKT1/2 抑制剂,10 uM ATP 下的 IC50 为 5.2/18 nM。
-
Afuresertib
一种有效的、选择性的 ATP 竞争性泛 AKT 抑制剂,对于 AKT1/2/3 的生化 IC50 为 0.08/2/2.6 nM。
-
TAS-117
TAS-117 是一种高选择性、非 ATP 竞争性泛 Akt 抑制剂,对 Akt1/Akt2/Akt3 的 IC50 值分别为 4.8/1.6/44 nM。